🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07534956
Recruiting Not applicable

The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients

NCT07534956 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-13
Last updated
2026-04-16

Condition(s) studied

Emergence Delirium in Pediatric AnesthesiaPediatric AnesthesiaPostoperative Agitations in Pediatric PatientsPostoperative Nausea and Vomiting (PONV)

Investigational drug(s) / intervention(s)

propofol ( Paedfusor Model) →propofol (Eleveld Model) →Sevofluorane

propofol ( Paedfusor Model): Propofol will be administered via target-controlled infusion using a Paedfusor model.

propofol (Eleveld Model): Propofol will be administered via target-controlled infusion using the Eleveld model.

Sevofluorane: Sevoflurane will be administered as an inhalation anesthetic.

Study summary

Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation/delirium by comparing them with each other and with inhalation anesthesia.

Eligibility

Sex
ALL
Min age
3 Years
Max age
10 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Children aged 3-10 years * Children weighing over 10 kg * American Society of Anesthesiologists (ASA) physical condition classification I-II * Those who will undergo planned urogenital surgery under general anesthesia * Those who have obtained written informed consent from their parents or legal guardians Exclusion Criteria: * Patients assessed as ASA III or higher * Known neurological or psychiatric disorders * Developmental delay or cognitive impairment * Use of sedatives or psychoactive drugs * Allergy or contraindication to the study drugs (propofol or sevoflurane) * History of previous adverse reactions to anesthesia * Patients requiring emergency surgery * Significant liver, kidney, or cardiovascular disease * Patients whose parents or legal guardians have not given consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Marmara University Pendik Research and Training Hospital Istanbul Turkey (Türkiye) Recruiting
Marmara University Pendik Research and Training Hospital Istanbul Turkey (Türkiye) Recruiting

More Marmara University Pendik Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07534956 on ClinicalTrials.gov ↗ ← All trials in Turkey